v3.25.2
Condensed Consolidated Statements of Stockholders' Equity / (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Non controlling Interest [Member]
Begning Balance at Dec. 31, 2023 $ (172,938)   $ 1 $ 407,828   $ (490,245) $ (90,522)  
Begning Balance (in shares) at Dec. 31, 2023   29,057 4,574          
Balance (in shares) at Dec. 31, 2023             1,716  
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement, Share     5          
Shares issued under Bought Deal Offering     168          
Shares issued under Bought Deal Offering 3,769     3,769        
Shares issued under Standby Equity Purchase Agreements and under ATM Sales Agreement, Value 156     156        
Stock options exercised 46     46        
Stock options exercised (in shares)     1          
Stock-based compensation 3,558     3,558        
Net Income (Loss) (24,377)         (24,377)    
Ending Balance at Mar. 31, 2024     $ 1 415,357   (514,622) $ (90,522)  
Balance, ( In shares) at Mar. 31, 2024             1,716  
Ending Balance (in shares) at Mar. 31, 2024   29,057 4,748          
Begning Balance at Dec. 31, 2023 (172,938)   $ 1 407,828   (490,245) $ (90,522)  
Begning Balance (in shares) at Dec. 31, 2023   29,057 4,574          
Balance (in shares) at Dec. 31, 2023             1,716  
Stock-based compensation 7,171              
Other comprehensive income 1,851              
Net Income (Loss) (61,959)              
Ending Balance at Jun. 30, 2024     $ 1 426,182 $ 1,851 (552,204) $ (90,522)  
Balance, ( In shares) at Jun. 30, 2024             1,716  
Ending Balance (in shares) at Jun. 30, 2024   29,057 5,185          
Begning Balance at Mar. 31, 2024     $ 1 415,357   (514,622) $ (90,522)  
Begning Balance (in shares) at Mar. 31, 2024   29,057 4,748          
Balance (in shares) at Mar. 31, 2024             1,716  
Shares issued under Registered Direct Offering, shares     429          
Shares issued under Registered Direct Offering 5,919     5,919        
April 2024 RDO Placement Agent Warrants issued in connection with April 2024 RDO and February 2024 BDO Representative Warrants issued in connection with February 2024 BDO 956     956        
Shares issued under ESPP, shares     5          
Shares issued under ESPP 154     154        
Stock options exercised 99     99        
Stock options exercised (in shares)     2          
Issuance of common stock upon warrants exercise, shares     1          
Issuance of common stock upon warrants exercise 84     84        
Stock-based compensation 3,613     3,613        
Other comprehensive income 1,851       1,851      
Net Income (Loss) (37,582)         (37,582)    
Ending Balance at Jun. 30, 2024     $ 1 426,182 1,851 (552,204) $ (90,522)  
Balance, ( In shares) at Jun. 30, 2024             1,716  
Ending Balance (in shares) at Jun. 30, 2024   29,057 5,185          
Begning Balance at Dec. 31, 2024 (192,641) $ 1 $ 1 454,614 6,317 (563,052) $ (90,522)  
Begning Balance (in shares) at Dec. 31, 2024   34,057 6,952          
Stockholders' Equity Beginning Balance at Dec. 31, 2024 (192,641)              
Balance (in shares) at Dec. 31, 2024             1,716  
Treasury Stock transferred to Tranche B Investors for Tranche B Notes deferral 2,182     (5,353)     $ 7,535  
Treasury Stock transferred to Tranche B Investors for Tranche B Note deferral, Shares             (143)  
Treasury Stock paid for Gloperba Ex-U.S. License 366     (808)     $ 1,174  
Treasury Stock paid for Gloperba Ex-U.S. License, Shares             (22)  
Treasury Stock transferred to Oramed for the Oramed Note maturity extension 1,375     (3,523)     $ 4,898  
Treasury Stock transferred to Oramed for the Oramed Note maturity extension, Shares             (93)  
Stock-based compensation 3,314     3,314        
Net Income (Loss) (26,080)         (26,080)   $ 0
Ending Balance at Mar. 31, 2025 (211,484) $ 1 $ 1 448,244 6,317 (589,132) $ (76,915)  
Balance, ( In shares) at Mar. 31, 2025             1,458  
Ending Balance (in shares) at Mar. 31, 2025   34,057 6,952          
Begning Balance at Dec. 31, 2024 (192,641) $ 1 $ 1 454,614 6,317 (563,052) $ (90,522)  
Begning Balance (in shares) at Dec. 31, 2024   34,057 6,952          
Stockholders' Equity Beginning Balance at Dec. 31, 2024 (192,641)              
Balance (in shares) at Dec. 31, 2024             1,716  
Stock-based compensation 6,593              
Other comprehensive income 0              
Net Income (Loss) (70,128)              
Ending Balance at Jun. 30, 2025 (248,987) $ 1 $ 1 453,049 6,317 (631,440) $ (76,915) 0
Balance, ( In shares) at Jun. 30, 2025             1,458  
Ending Balance (in shares) at Jun. 30, 2025   34,057 6,956          
Stockholders' Equity Ending Balance at Jun. 30, 2025 (248,987)              
Begning Balance at Mar. 31, 2025 (211,484) $ 1 $ 1 448,244 6,317 (589,132) $ (76,915)  
Begning Balance (in shares) at Mar. 31, 2025   34,057 6,952          
Balance (in shares) at Mar. 31, 2025             1,458  
Shares issued under ESPP, shares     4          
Payments in lieu of fractional shares for Reverse Stock Split (1)     (1)        
Shares issued under ESPP 17     17        
Acquisition of controlling interest in joint venture 3,250     1,510       1,740
Stock-based compensation 3,279     3,279        
Other comprehensive income 0              
Net Income (Loss) (44,048)         (42,308)   (1,740)
Ending Balance at Jun. 30, 2025 (248,987) $ 1 $ 1 $ 453,049 $ 6,317 $ (631,440) $ (76,915) $ 0
Balance, ( In shares) at Jun. 30, 2025             1,458  
Ending Balance (in shares) at Jun. 30, 2025   34,057 6,956          
Stockholders' Equity Ending Balance at Jun. 30, 2025 $ (248,987)